Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 2,141 filings

Top spenders & firms Spend by issue Political contributions Revolving door

Clear
Q2
GUIDEPOSTSTRATEGIES, LLC for UNITEDHEALTH GROUP, INC.
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $90,000.00 income
Health Issues, Medicare/Medicaid, Pharmacy
View →
Q2
B HALL STRATEGIES, LLC for TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF PHRMA
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · Senate · $50,000.00 income
Pharmacy
View →
Q2
B HALL STRATEGIES, LLC for TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF NOVARTIS
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · Senate · $30,000.00 income
Pharmacy
View →
Q2
B HALL STRATEGIES, LLC for TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF GENENTECH, INC.
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · Senate · $30,000.00 income
Pharmacy
View →
Q2
B HALL STRATEGIES, LLC for TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF ELI LILLY AND COMPANY
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · Senate · $30,000.00 income
Pharmacy
View →
Q2
B HALL STRATEGIES, LLC for TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF AMGEN, INC.
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · Senate · $50,000.00 income
Pharmacy
View →
Q2
B HALL STRATEGIES, LLC for TIBER CREEK GROUP ON BEHALF OF TAKEDA PHARMACEUTICALS AMERICA, INC.
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · Senate · $30,000.00 income
Pharmacy
View →
Q2
B HALL STRATEGIES, LLC for TIBER CREEK GROUP ON BEHALF OF PHLOW CORPORATION
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · Senate · $30,000.00 income
Pharmacy
View →
Q2
B HALL STRATEGIES, LLC for TIBER CREEK GROUP ON BEHALF OF ORGANON, LLC
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · Senate · $30,000.00 income
Pharmacy
View →
Q2
B HALL STRATEGIES, LLC for TIBER CREEK GROUP ON BEHALF OF MERCK & CO., INC.
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · $30,000.00 income
Pharmacy
View →
Q2
B HALL STRATEGIES, LLC for TIBER CREEK GROUP ON BEHALF OF GILEAD SCIENCES, INC.
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · Senate · $30,000.00 income
Pharmacy
View →
Q2
B HALL STRATEGIES, LLC for TIBER CREEK GROUP ON BEHALF OF DAIICHI SANKYO, INC.
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · Senate · $30,000.00 income
Pharmacy
View →
Q2
B HALL STRATEGIES, LLC for TIBER CREEK GROUP ON BEHALF OF BEONE MEDICINES USA, INC.
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · Senate · $30,000.00 income
Pharmacy
View →
Q2
B HALL STRATEGIES, LLC for TIBER CREEK GROUP ON BEHALF OF ASTELLAS PHARMA US, INC.
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · $30,000.00 income
Pharmacy
View →
Q2
BURRELL INTERNATIONAL GROUP LLC for TONIX PHARMACEUTICALS HOLDING CORP.
2nd Quarter (Apr 1 - June 30) 2026 · New Jersey · House · Senate · $40,000.00 income
Pharmacy
View →
Q2
BURRELL INTERNATIONAL GROUP LLC for SHIONOGI INC.
2nd Quarter (Apr 1 - June 30) 2026 · New Jersey · House · Senate · $40,000.00 income
Pharmacy
View →
Q2
AMERICAN SOCIETY OF CONSULTANT PHARMACISTS for AMERICAN SOCIETY OF CONSULTANT PHARMACISTS
2nd Quarter (Apr 1 - June 30) 2026 · Virginia · House · Senate
Health Issues, Medicare/Medicaid, Pharmacy
View →
Q2
RUBIN, TURNBULL & ASSOCIATES for ASSOCIATION FOR ACCESSIBLE MEDICINES
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · $150,000.00 income
Pharmacy, Health Issues
View →
Q2
RUBIN, TURNBULL & ASSOCIATES for PHRMA
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · $90,000.00 income
Pharmacy, Health Issues
View →
2T
RUBIN, TURNBULL & ASSOCIATES for USANTIBIOTICS
2nd Quarter (Apr 1 - June 30) 2026 · Tennessee · $90,000.00 income
Pharmacy
View →
Q2
BLUECROSS BLUESHIELD OF TENNESSEE for BLUECROSS BLUESHIELD OF TENNESSEE
2nd Quarter (Apr 1 - June 30) 2026 · Tennessee · House · Senate
Health Issues, Medicare/Medicaid, Pharmacy
View →
Q2
HB STRATEGIES (FKA HUSCH BLACKWELL STRATEGIES) for BAYER U.S. LLC
2nd Quarter (Apr 1 - June 30) 2026 · New Jersey · House · Senate · $120,000.00 income
Health Issues, Agriculture, Pharmacy
View →
Q2
ARENTFOX SCHIFF LLP for PHARVARIS, INC.
2nd Quarter (Apr 1 - June 30) 2026 · Massachusetts · House · Senate · $40,000.00 income
Medicare/Medicaid, Pharmacy
View →
Q2
CROSSROADS STRATEGIES, LLC for BLINK HEALTH, INC.
2nd Quarter (Apr 1 - June 30) 2026 · New York · House · Senate · $120,000.00 income
Pharmacy
View →
Q2
BROYDRICK & ASSOCIATES for TONIX PHARMACEUTICALS
2nd Quarter (Apr 1 - June 30) 2026 · New York · House · Senate · $20,000.00 income
Pharmacy
View →
Previous Page 8 of 86 Next

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem